Active-specific immunization against melanoma: Is the problem at the receiving end?
- 31 December 2003
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 13 (6) , 473-480
- https://doi.org/10.1016/j.semcancer.2003.09.011
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cellsEuropean Journal of Immunology, 2002
- Introduction to the SeriesScandinavian Journal of Immunology, 2001
- IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanomaGenes & Immunity, 2001
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- Three new DPB1 alleles identified in a Bantu‐speaking population from central CameroonTissue Antigens, 1996
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991